# Global Health Ltd (MEDANTA)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹1238.1
Day Change: -0.17%
52W High: ₹1456.5
52W Low: ₹956
Market Cap: ₹33,168 Cr

## Valuation
P/E: 59.84
P/B: 8.96
EPS: ₹20.63
Book Value: ₹137.83
Dividend Yield: 0.04%

## Returns
1Y Return: 5.57%

## Profitability
ROE: 15.03%
ROCE: 26.41%
Debt/Equity: 0.3
Revenue Growth: 24.5%
Profit Growth: 42%
EBITDA Margin: 20.84%
Operating Margin: 15.29%

## About
Global Health Ltd is a Medical Care Facilities company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Medical Care Facilities
Sub Industry: Unknown

## Business Model
Overview: Global Health Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Care Facilities. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

## Access
Current tier: anonymous
More history: Register free to see 6 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:13.396Z
Price History Updated: 2026-05-18T22:58:12.631Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:12.631Z
Quant Updated: 2026-05-18T22:58:12.631Z
Sentiment Updated: 2026-05-18T22:58:12.631Z
Financials Status: current
Financials Updated: 2026-05-18T08:30:24.585Z
Financials Last Attempt: 2026-05-18T08:30:24.585Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2018)
Revenue: ₹1382 Cr
Operating Profit: ₹301 Cr (OPM 22%)
Net Profit: ₹170 Cr
Tax: ₹262 Cr

## Annual P&L History
Mar 2018: Rev ₹1382Cr | PAT ₹170Cr | OPM 22%
Mar 2019: Rev ₹1343Cr | PAT ₹33Cr | OPM 9%
Mar 2020: Rev ₹1456Cr | PAT ₹51Cr | OPM 12%

## Balance Sheet (Mar 2018)
Total Assets: ₹1485 Cr
Total Liabilities: ₹1485 Cr
Borrowings: ₹165 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Naresh Kumar Trehan, Chairman & MD
- Pankaj Prakash Sahni, Group CEO & Additional Whole Time Director
- Yogesh Kumar Gupta, Chief Financial Officer
- Rajiv  Sikka, Chief Information Officer
- Rahul  Ranjan, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/medanta
Disclaimer: For research and education only. Not investment advice.